Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Bicycle Therapeutics PLC Sponsored ADR (BCYC) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$0.89M
Net Income	$-60.83M
Cost of Goods Sold	--
Gross Profit	$0.89M
Operating Expenses	$66.37M
Operating Income	$-65.48M
Non-Operating Income/Expense	$4.83M
Pre-Tax Income	$-60.65M
Normalized Pre-Tax Income	$-60.65M
Income after Taxes	$-60.83M
Income from Continuous Operations	$-60.83M
Consolidated Net Income/Loss	$-60.83M
Normalized Income after Taxes	$-60.83M
EBIT	$-65.48M
EBITDA	$-64.35M
Weighted-Average Shares Outstanding (Basic)	69.68M
Weighted-Average Shares Outstanding (Diluted)	69.68M
Earnings per Share (EPS) (Basic)	$-0.87
Earnings per Share (EPS) (Diluted)	$-0.87
Balance Sheet Financials
Current Assets	$619.13M
Property, Plant, and Equipment	$5.73M
Long-Term Assets	$33.26M
Total Assets	$652.40M
Current Liabilities	$48.89M
Long-Term Debt	--
Long-Term Liabilities	$49.19M
Total Liabilities	$98.08M
Common Equity	$554.32M
Tangible Shareholders Equity	$554.32M
Shareholders Equity	$554.32M
Common Shares Outstanding	69.71M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-65.92M
Cash Flow from Investing Activities	$-0.71M
Cash Flow from Financial Activities	$-0.05M
Beginning Cash	$628.72M
End Cash	$560.08M
Increase/Decrease in Cash	$-68.64M
Stock-Based Compensation	$6.93M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	12.66
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	100.00%
Operating Margin	-7382.41%
EBIT Margin	-7382.41%
EBITDA Margin	--
Pre-Tax Profit Margin	-6837.99%
Profit Margin	-6857.38%
Free Cash Flow	$-66.64M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.00
Inventory Turnover	--
Receiveable Turnover	0.02
Days Sales in Receivables	4151.67
Return on Equity	-10.97%
Return on Tangible Equity	-10.97%
Return on Assets	-9.32%
Return on Investments	-10.97%
Book Value Per Share	$7.95
Free Cash Flow per Share	$-0.96
Operating Cash Flow per Share	$-0.95

Data from Zacks Investment Research, Inc.